{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:10:47Z","timestamp":1787771447434,"version":"build-2784847793"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ijantimicag.2020.105935","type":"journal-article","created":{"date-parts":[[2020,3,8]],"date-time":"2020-03-08T17:22:47Z","timestamp":1583688167000},"page":"105935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Fosfomycin trometamol and N-acetyl-L-cysteine as combined oral therapy of difficult-to-treat chronic bacterial prostatitis: Results of a pilot study"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7234-3526","authenticated-orcid":false,"given":"Tommaso","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Tamanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9892-5535","authenticated-orcid":false,"given":"Daniele","family":"Mattevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Verze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Malossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Mirone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Tascini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truls E. Bjerklund","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijantimicag.2020.105935_bib0001","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/QCO.0000000000000222","article-title":"Bacterial prostatitis","volume":"29","author":"Gill","year":"2016","journal-title":"Curr Opin Infect Dis"},{"issue":"8","key":"10.1016\/j.ijantimicag.2020.105935_bib0002","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00345-015-1722-1","article-title":"Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003-2013","volume":"34","author":"Tando\u011fdu","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.ijantimicag.2020.105935_bib0003","unstructured":"European Association of Urology Guidelines on Urological Infections. 2018. http:\/\/uroweb.org\/wp-content\/uploads\/19-Urological-infections_LR2.pdf."},{"issue":"2","key":"10.1016\/j.ijantimicag.2020.105935_bib0004","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00345-016-1867-6","article-title":"Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative","volume":"35","author":"Cai","year":"2017","journal-title":"World J Urol"},{"issue":"2","key":"10.1016\/j.ijantimicag.2020.105935_bib0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41391-018-0032-2","article-title":"Fosfomycin vs. quinolone-based antibiotic prophylaxis for transrectal ultrasound-guided biopsy of the prostate: a systematic review and meta-analysis","volume":"21","author":"Noreikaite","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"10.1016\/j.ijantimicag.2020.105935_bib0006","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/1120009X.2018.1500110","article-title":"The use of oral fosfomycin-trometamol in patients with catheter-associated urinary tract infections (CAUTI): new indications for an old antibiotic?","volume":"30","author":"Cai","year":"2018","journal-title":"J Chemother"},{"issue":"3","key":"10.1016\/j.ijantimicag.2020.105935_bib0007","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1128\/AAC.02611-15","article-title":"Long-term fosfomycin-tromethamine oral therapy for difficult-to-treat chronic bacterial prostatitis","volume":"60","author":"Los-Arcos","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.ijantimicag.2020.105935_bib0008","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/cid\/civ436","article-title":"Fosfomycin for treatment of prostatitis: new tricks for old dogs","volume":"61","author":"Grayson","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ijantimicag.2020.105935_bib0009","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4111\/icu.2018.59.3.187","article-title":"Prostate calcifications: A case series supporting the microbial biofilm theory","volume":"59","author":"Cai","year":"2018","journal-title":"Investig Clin Urol"},{"issue":"3","key":"10.1016\/j.ijantimicag.2020.105935_bib0010","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00345-013-1145-9","article-title":"The impact of biofilm-producing bacteria on chronic bacterial prostatitis treatment: results from a longitudinal cohort study","volume":"32","author":"Bartoletti","year":"2014","journal-title":"World J Urol"},{"issue":"3","key":"10.1016\/j.ijantimicag.2020.105935_bib0011","article-title":"In vitro synergism of colistin and N-acetylcysteine against Stenotrophomonas maltophilia","volume":"8","author":"Ciacci","year":"2019","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"10.1016\/j.ijantimicag.2020.105935_bib0012","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/s10753-016-0327-1","article-title":"N-acetylcysteine ameliorates prostatitis via miR-141 regulating Keap1\/Nrf2 signaling","volume":"39","author":"Wang","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.ijantimicag.2020.105935_bib0013","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.eururo.2004.12.025","article-title":"The Italian version of the National Institutes of Health Chronic Prostatitis Symptom Index","volume":"47","author":"Giubilei","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijantimicag.2020.105935_bib0014","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000474438","article-title":"Ten-language translation and harmonization of the International Prostate Symptom Score: developing a methodology for multinational clinical trials","volume":"31","author":"Badia","year":"1997","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijantimicag.2020.105935_bib0015","first-page":"478","article-title":"Health status: types of validity and the index of wellbeing","volume":"11","author":"Kaplan","year":"1976","journal-title":"Health Serv Res"},{"issue":"3","key":"10.1016\/j.ijantimicag.2020.105935_bib0016","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4081\/aiua.2016.3.177","article-title":"Serenoa repens associated with selenium and lycopene extract and bromelain and methylsulfonylmethane extract are able to improve the efficacy of levofloxacin in chronic bacterial prostatitis patients","volume":"88","author":"Cai","year":"2016","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.ijantimicag.2020.105935_bib0017","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0022-5347(05)66541-X","article-title":"Prevalence of prostatitis prostatitis-like symptoms population based study using the National Institutes of Health chronic prostates symptoms index","volume":"165","author":"Nickel","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.ijantimicag.2020.105935_bib0018","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijantimicag.2020.105935_bib0019","first-page":"71","article-title":"Conventional bacteriology in prostatitis patients: microbiological bias, problems and epidemiology on 1686 microbial isolates","volume":"79","author":"Mazzoli","year":"2007","journal-title":"Arch Ital Urol Androl"},{"issue":"5","key":"10.1016\/j.ijantimicag.2020.105935_bib0020","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.eururo.2006.10.059","article-title":"Interleukin 8 and anti-chlamydia trachomatis mucosal IgA as urogenital immunologic markers in patients with C. trachomatis prostatic infection","volume":"51","author":"Mazzoli","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijantimicag.2020.105935_bib0021","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.ijantimicag.2020.105935_bib0022","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-5347(06)00498-8","article-title":"How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis\/chronic pelvic pain syndrome?","volume":"176","author":"Nickel","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.ijantimicag.2020.105935_bib0023","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.rmed.2016.06.015","article-title":"The effect of N-acetylcysteine on biofilms: Implications for the treatment of respiratory tract infections","volume":"117","author":"Blasi","year":"2016","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.ijantimicag.2020.105935_bib0024","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/lam.12513","article-title":"N-Acetyl-L-cysteine effects on multi-species oral biofilm formation and bacterial ecology","volume":"62","author":"Rasmussen","year":"2016","journal-title":"Lett Appl Microbiol"},{"issue":"10","key":"10.1016\/j.ijantimicag.2020.105935_bib0025","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.ajic.2017.05.009","article-title":"Bacterial biofilm-based catheter-associated urinary tract infections: Causative pathogens and antibiotic resistance","volume":"45","author":"Sabir","year":"2017","journal-title":"Am J Infect Control"},{"issue":"7","key":"10.1016\/j.ijantimicag.2020.105935_bib0026","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1093\/jac\/dkv067","article-title":"Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis","volume":"70","author":"Rhodes","year":"2015","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920300856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920300856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T19:32:11Z","timestamp":1735673531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857920300856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0924857920300856"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105935","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fosfomycin trometamol and N-acetyl-L-cysteine as combined oral therapy of difficult-to-treat chronic bacterial prostatitis: Results of a pilot study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105935"}}